THANGAMAYL.BO(THANGAMAYL.BO)
THANGAMAYL.BO
No analyst ratings available
No analyst price targets available for THANGAMAYL.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $106.55B | $126.09B | $145.67B |
| Low | $96.49B | $113.53B | $131.50B |
| High | $115.63B | $133.92B | $156.26B |
| EBITDA Avg | $5.42B | $6.42B | $7.41B |
| Low | $4.91B | $5.78B | $6.69B |
| High | $5.88B | $6.81B | $7.95B |
| EBIT Avg | $4.94B | $5.85B | $6.76B |
| Low | $4.48B | $5.27B | $6.10B |
| High | $5.36B | $6.21B | $7.25B |
| Net Income Avg | $4.32B | $5.02B | $6.02B |
| Low | $4.21B | $4.82B | $5.85B |
| High | $4.44B | $5.22B | $6.18B |
| EPS Avg | $138.10 | $161.70 | $193.55 |
| Low | $135.50 | $155.22 | $188.30 |
| High | $142.78 | $167.87 | $198.80 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 2 / 2 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|---|
| Revenue Avg | $20.53B | $22.72B | $29.96B | $34.32B |
| Low | $20.53B | $22.72B | $29.96B | $34.32B |
| High | $20.53B | $22.72B | $29.96B | $34.32B |
| EBITDA Avg | $1.04B | $1.16B | $1.52B | $1.75B |
| Low | $1.04B | $1.16B | $1.52B | $1.75B |
| High | $1.04B | $1.16B | $1.52B | $1.75B |
| EBIT Avg | $952M | $1.05B | $1.39B | $1.59B |
| Low | $952M | $1.05B | $1.39B | $1.59B |
| High | $952M | $1.05B | $1.39B | $1.59B |
| Net Income Avg | $675M | $858M | $1.33B | $1.41B |
| Low | $675M | $858M | $1.33B | $1.41B |
| High | $675M | $858M | $1.33B | $1.41B |
| EPS Avg | $21.70 | $27.60 | $42.80 | $45.40 |
| Low | $21.70 | $27.60 | $42.80 | $45.40 |
| High | $21.70 | $27.60 | $42.80 | $45.40 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |